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Abstract
Repeated intermittent exposure to psychostimulants and morphine leads to progressive augmentation of its locomotor
activating effects in rodents. Accumulating evidence suggests the critical involvement of the mesocorticolimbic
dopaminergic neurons, which project from the ventral tegmental area to the nucleus accumbens and the medial
prefrontal cortex, in the behavioral sensitization. Here, we examined the acute and chronic effects of psychostimulants and
morphine on dopamine release in a reconstructed mesocorticolimbic system comprised of a rat triple organotypic slice co-
culture of the ventral tegmental area, nucleus accumbens and medial prefrontal cortex regions. Tyrosine hydroxylase-
positive cell bodies were localized in the ventral tegmental area, and their neurites projected to the nucleus accumbens and
medial prefrontal cortex regions. Acute treatment with methamphetamine (0.1–1000 mM), cocaine (0.1–300 mM) or
morphine (0.1–100 mM) for 30 min increased extracellular dopamine levels in a concentration-dependent manner, while 3,4-
methylenedioxyamphetamine (0.1–1000 mM) had little effect. Following repeated exposure to methamphetamine (10 mM)
for 30 min every day for 6 days, the dopamine release gradually increased during the 30-min treatment. The augmentation
of dopamine release was maintained even after the withdrawal of methamphetamine for 7 days. Similar augmentation was
observed by repeated exposure to cocaine (1–300 mM) or morphine (10 and 100 mM). Furthermore, methamphetamine-
induced augmentation of dopamine release was prevented by an NMDA receptor antagonist, MK-801 (10 mM), and was not
observed in double slice co-cultures that excluded the medial prefrontal cortex slice. These results suggest that repeated
psychostimulant- or morphine-induced augmentation of dopamine release, i.e. dopaminergic sensitization, was reproduced
in a rat triple organotypic slice co-cultures. In addition, the slice co-culture system revealed that the NMDA receptors and
the medial prefrontal cortex play an essential role in the dopaminergic sensitization. This in vitro sensitization model
provides a unique approach for studying mechanisms underlying behavioral sensitization to drugs of abuse.
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Introduction
Psychostimulants (e.g. amphetamines and cocaine) and opiates (e.g.
morphine) share the ability to cause drug dependence and addiction. In
rodents, repeated intermittent exposure to psychostimulants and
morphine leads to progressive augmentation of their locomotor
activating effects. This phenomenon, termed behavioral sensitization,
is thought to underlie certain aspects of drug addiction [1]. It is well
established that the drug-associated behaviors including locomotor and
rewarding effect of such drugs depend on their ability to elevate
extracellular dopamine levels in the mesocorticolimbic dopaminergic
neurons that originate in the ventral tegmental area (VTA) and project
to the nucleus accumbens (NAc), the medial prefrontal cortex (mPFC)
and other forebrain regions [2].
The effect of amphetamines on dopamine release is mainly
attributed to their binding to and reversal of dopamine transporter
(DAT) function, resulting in both reuptake inhibition and release of
dopamine [3], while cocaine inhibits reuptake of dopamine at the
mesocorticolimbic dopaminergic nerve terminals. Opioids inhibit the
inhibitory c-amino-butyric acid (GABA) interneurons in the VTA
through m-opioid receptor activation and subsequently activate the
mesocorticolimbic dopaminergic neurons [4]. A body of evidence
suggests that repeated exposure to psychostimulants and morphine
augments the dopamine release in the NAc [5–8] and mPFC [9,10],
which contributes to their behavioral sensitization [11,12], although
the altered dopamine release in the mPFC under sensitization state is
dependent on the regimen and withdrawal days [10,13–15]. On the
other hand, the mesocorticolimbic dopaminergic neurons could be
regulated by the glutamatergic neurons through N-methyl-D-aspartate
(NMDA) and non-NMDA receptors, which are innervated from the
limbic and cortical areas, such as the mPFC, hippocampus and
amygdala to the NAc [16,17]. It is suggested that neuroadaptations in
interaction between the mesocorticolimbic dopaminergic and gluta-
matergic system in the NAc by repeated exposure to psychostimulants
and opioids play an important role in drug addiction [11,18,19].
Many aspects of drug addiction have been assessed by in vivo
experiments in whole animals, because these addiction-related
phenomena are thought to be due to long-term alterations in
psychological behavior caused by synaptic plasticity in the
mesocorticolimbic dopaminergic neurons. Acute effects of drugs
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assessed by in vitro experiments using cell lines expressing DAT
[20,21], primary cultures of dopaminergic neurons [22] or acute
striatal or mesencephalic slice preparations [23–25]. However, in
vitro culture systems that recapitulate cell-to-cell interactions
between different parts of the brain are anticipated to provide
much valuable data about the long-term effects of drugs,
facilitating investigations of the neural plasticity underlying drug
addiction.
To this end, Maeda et al. reconstructed the mesocorticolimbic
system using rat triple organotypic slice co-cultures of the
mesencephalic slice including the VTA, the ventral striatal slice
including the NAc, and the mPFC slice [26]. Using an
extracellular recording technique with a multi-electrode dish, they
showed that the triple slice co-cultures retained a functional
corticoaccumbens glutamatergic pathway from the mPFC to the
NAc. Furthermore, they found that cocaine attenuated the
synaptic activity of the corticoaccumbens pathway through
activation of D1-like, but not D2-like, dopamine receptors [26].
These findings demonstrate that the triple slice co-cultures retain
functional interactions between the mesocorticolimbic dopami-
nergic and corticoaccumbens glutamatergic pathways in the NAc.
Thus, the VTA/NAc/mPFC triple slice co-cultures are ideal for
the analysis of acute and chronic effect of drugs of abuse.
To explore the utility of the triple slice co-cultures for studying
certain processes relevant to behavioral sensitization in vitro,w e
examined the effects of acute and chronic effects of psychostim-
ulants and morphine on dopamine release. Here we report that
repeated exposure of the triple slice co-cultures to methamphet-
amine (METH), cocaine or morphine augmented their dopamine
releasing effects, i.e. dopaminergic sensitization. Furthermore, we
examined the involvement of NMDA receptors and the mPFC in
the dopaminergic sensitization.
Results
Histological studies
To assess the reconstruction of the mesocorticolimbic dopami-
nergic neurons in the VTA/NAc/mPFC triple slice co-cultures,
immunostaining was performed for tyrosine hydroxylase (TH), the
rate-limiting enzyme in the biosynthesis of catecholamines
(Fig. 1A–F). TH-positive cells and neurites were clearly observed
by bright field or fluorescence microscopy. A number of TH-
positive cell bodies were localized in the VTA of the mesence-
phalic slices. The TH-positive neurites were abundantly observed
in the mesencephalic slices, and they were also observed in the
ventral striatal and mPFC slices, which crossed the VTA-NAc and
VTA-mPFC borders. Furthermore, Western blot revealed that
DAT was expressed in the VTA, NAc and mPFC parts of the
triple slice co-cultures (Fig. 1G).
Effects of single treatment with psychostimulants and
morphine on dopamine release
The effects of single treatment of the VTA/NAc/mPFC triple
slice co-cultures with METH, cocaine, MDMA or morphine on
dopamine release were examined (Fig. 2). Single treatment with
METH (0.1–1000 mM), cocaine (0.1–300 mM) or morphine (0.1–
100 mM) for 30 min significantly increased the extracellular
dopamine level in a concentration-dependent manner (METH;
F5,22=11.22, p,0.001, cocaine; F5,40=3.857, p,0.01, morphine;
F4,13=15.21, p,0.001). Significant increases were observed by
METH at concentrations of 100 and 1000 mM( p,0.001), cocaine
at concentrations of 100 and 300 mM( p,0.05 and p,0.01,
respectively) and morphine at a concentration of 100 mM
(p,0.001), compared with phosphate-buffered saline (PBS)-treated
triple slice co-cultures. Single treatment with 3,4-methylenediox-
ymethamphetamine (MDMA; 0.1–1000 mM) for 30 min tended to
increase the extracellular dopamine level, although this increase
was not significant (F5,15=1.915, p=0.151).
Effects of repeated exposure to psychostimulants and
morphine on dopamine release
To examine the effect of repeated exposure to METH on
dopamine release, the VTA/NAc/mPFC triple slice co-cultures
were exposed to METH at a concentration of 10 mM in Krebs-
Ringer-Henseleit (KRH) buffer for 30 min every day for 6 days
Figure 1. Immunohistochemistry for TH in the VTA/NAc/mPFC
triple slice co-cultures. (A) Photomicrograph for TH immunoreactiv-
ity by 3,39-diaminobenzidine staining in a representative triple slice co-
culture. The dotted lines represent the borders of mesencephalic,
ventral striatal and mPFC slices. Scale bar=1 mm. (B–F) Fluorescence
photomicrographs for TH immunoreactivity in the (B) VTA in the
mesencephalic slice, (C) border of mesencephalic and mPFC slices, (D)
mPFC slice, (E) border of mesencephalic and ventral striatal slices and
(F) NAc in the ventral striatal slice. Square frames in the illustration of
the VTA/NAc/mPFC triple slice co-culture indicate the regions
corresponding to the photomicrographs (B)–(F). Scale bar=50 mm. (G)
The expression of DAT protein (approximately 75 kDa) in the VTA, NAc
and mPFC parts separated from the triple slice co-cultures was
determined by Western blotting (upper panel). Lower panel shows
blots for Na
+/K
+-ATPase (approximately 100 kDa) as a loading control.
doi:10.1371/journal.pone.0024865.g001
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gradually at every METH exposure, while repeated PBS exposure
caused no such effect (Fig. 3A). Significant day (F5,25=5.007,
p,0.01) and drug effects (F1,25=54.72, p,0.001) were observed as
well as a day6drug significant interaction (F5,25=5.697, p,0.01).
On day 7, both repeated METH- and PBS-exposed co-cultures
were challenged by METH at a concentration of 10 mM for
30 min (Fig. 3B). The METH challenge-evoked dopamine release
in the repeated METH-exposed triple slice co-cultures was
significantly increased compared with that in the repeated PBS-
exposed co-cultures (p,0.01). The effect of withdrawal of METH
on the repeated METH induced-augmentation of dopamine
release was examined (Fig. 3C). When METH was withdrawn for
4 and 7 days following the repeated exposure to METH (10 mM)
for 6 days, the METH challenge-evoked dopamine release was still
augmented significantly compared with that in the single METH
treatment on Day 1 (p,0.001 and p,0.01, respectively).
Next, we examined the concentration-dependence of the
repeated METH induced-augmentation of dopamine release
(Fig. 4A). The triple slice co-cultures were exposed to PBS or
METH (1–1000 mM) in the cultured medium for 30 min every
day for 6 days, and then the co-cultures were challenged on day 7
with METH at a concentration of 10 mM in KRH buffer for
30 min. Consistent with the above results, repeated METH
exposure significantly increased the extracellular dopamine level
following METH challenge (F4,21=8.953, p,0.001). Repeated
METH exposure displayed a bell-shaped curve of concentration-
dependence; the METH challenge-evoked dopamine releases
following the repeated METH exposure at concentrations of 100
and 1000 mM were lower than those following the repeated
METH exposure at a concentration of 10 mM. Compared with
the slice co-cultures repeatedly exposed to PBS, a significant
increase in the extracellular dopamine level was observed in the
slice co-cultures repeatedly exposed to METH at a concentration
of 10 mM( p,0.001).
The triple slice co-cultures were exposed to cocaine (1–300 mM)
or morphine (10 and 100 mM) for 30 min every day for 6 days,
and then the co-cultures were challenged with cocaine (10 mM) or
morphine (100 mM), respectively, in KRH buffer for 30 min on
day 7 (Fig. 4B and C). Repeated cocaine or morphine exposure
significantly increased the extracellular dopamine level
(F4,20=3.514, p,0.05 and F2,14=4.572, p,0.05, respectively) in
a concentration-dependent manner. Compared with co-cultures
repeatedly exposed to PBS, significant increases in the extracel-
lular dopamine level were observed by the repeated exposure to
cocaine at a concentration of 300 mM( p,0.05) and morphine at a
concentration of 100 mM( p,0.05).
Involvement of NMDA receptors and the mPFC in the
repeated METH-induced augmentation of dopamine
release
To investigate whether NMDA receptors are involved in the
induction of the augmentation of dopamine release following the
repeated exposure to METH, we examined the effect of the
NMDA receptor antagonist MK-801 (Fig. 5A). The VTA/NAc/
mPFC triple slice co-cultures were co-exposed to METH (10 mM)
with MK-801 (10 mM) or PBS for 30 min every day for 6 days. On
day 7, the extracellular dopamine level following the METH
challenge (10 mM) was not altered with co-exposure to MK-801 in
the slice co-cultures repeatedly exposed to PBS. However, in the
slice co-cultures repeatedly exposed to METH, the extracellular
dopamine level following METH challenge was significantly
lowered by co-exposure to MK-801, compared with co-exposure
to PBS (p,0.05).
Next, to examine the role of mPFC region in the augmentation
of dopamine release following repeated METH exposure, the slice
Figure 2. Effect of single treatment with METH, cocaine, MDMA or morphine on the extracellular dopamine level in the VTA/NAc/
mPFC triple slice co-cultures. The triple slice co-cultures were treated with METH (0.1–1000 mM; A), cocaine (0.1–300 mM; B), MDMA (0.1–1000 mM;
C) or morphine (0.1–1000 mM; D) for 30 min in KRH buffer, and then the extracellular dopamine levels were determined. Values represent means of
the dopamine concentration 6 S.E.M. METH, n=3–7; cocaine, n=3–10; MDMA, n=3–5; morphine, n=3–5. *p,0.05, **p,0.01, ***p,0.001 versus
PBS-treated slice co-cultures.
doi:10.1371/journal.pone.0024865.g002
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slices were used without the mPFC slices (Fig. 5B). After repeated
exposure to METH (10 mM) for 30 min every day for 6 days,
METH challenge (10 mM) on day 7 significantly increased the
extracellular dopamine level in the VTA/NAc/mPFC triple slice
co-cultures, while the repeated METH-induced augmentation of
dopamine release was not observed in the VTA/NAc double slice
co-cultures without the mPFC slices. The difference between the
slice co-cultures with (triple slice co-cultures) and without (double
slice co-cultures) the mPFC slices was significant (p,0.001).
Discussion
To analyze the mechanisms underlying drug sensitization, we
reconstructed the mesocorticolimbic system using rat organotypic
triple VTA/NAc/mPFC slice co-cultures, as previously reported
by Maeda et al. [26]. This system, which retains neural and
synaptic function, enables long-term analysis and has clear
advantages compared with single cell culture systems. Immuno-
histochemical analysis revealed that TH-positive dopaminergic cell
bodies were observed within the VTA region, and TH-positive
neurites extended into the NAc and mPFC, target regions
observed in vivo [27]. Furthermore, DAT, the direct target of
psychostimulants on dopaminergic terminals, was observed in the
VTA, NAc and mPFC parts. These results suggest that the triple
slice co-culture retained in vivo physiology and allowed innervation
of the mesocorticolimbic dopaminergic neurons. On the other
hand, the mPFC is shown to connect to the NAc through the
corticoaccumbens glutamatergic pathway [28]. In the same triple
slice co-cultures, Maeda et al. reported that neurites of the mPFC
extended into the NAc region, and the corticoaccumbens pathway
consisted of functional glutamatergic neurons [26].
In the triple slice co-culture, single treatment with METH and
cocaine caused dopamine release in a concentration-dependent
manner. METH directly acts on DAT located on dopaminergic nerve
terminals and reverses dopamine reuptake, resulting in both reuptake
inhibition and release of dopamine. In contrast, cocaine only blocks
reuptake of dopamine at dopaminergic nerve terminals [29]. The
present findings that cocaine elevated extracellular dopamine levels
suggest that the mesocorticolimbic dopaminergic neurons in the triple
slice co-culture spontaneously release dopamine, and that the triple
slice co-culture has functional DAT and dopaminergic nerve terminals.
On the other hand, the effect of MDMA on dopamine release was
lowercomparedwith METH andcocaine in the triple slice co-cultures.
These results suggest that the direct action of MDMA on the
dopaminergic neurons, likely via a DAT-mediated mechanism, is
weak, as previously shown [30,31]. It is known that dopamine releasein
vivo is mediated through indirect mechanisms via MDMA-induced
serotonergic activation and direct DAT reversal [30,31], although the
dopaminergic-serotonergic interaction has not been examined in the
triple slice co-culture. Similarly, single treatment with morphine caused
dopamine release in the triple slice co-cultures that was concentration-
dependent. The morphine-evoked dopamine release is considered to
be due to inhibition of the inhibitory GABAergic interneurons in the
VTA through activation of m-opioid receptors to activate the
mesocorticolimbic dopaminergic neurons [4].
However, the concentrations required for the dopamine release
induced by single treatment with METH, cocaine and morphine
in the triple slice co-cultures are higher than those reported in
other in vitro systems, namely cell lines expressing DAT [20,21]
and primary cultures of dopaminergic neurons [22]. In the
preparation described here, because the level of dopamine was
measured in the absence of monoamine oxidase inhibitors,
dopamine might have been rapidly degraded by monoamine
oxidases before it spilled over into the KRH buffer. In addition,
unlike dissociated cultured cells, the slice culture is thick and its
surface is covered by numerous glial cells, which might limit the
diffusion of the drugs into the neurons.
A number of in vivo studies have indicated that repeated
intermittent exposure to psychostimulants and morphine leads to
the augmentation of dopamine release from the mesocorticolimbic
dopaminergic terminals in the NAc and mPFC, which is thought
to be the major cause of the behavioral sensitization ([1,5–10]; but
see [13–15]). In the present study, we found that repeated
exposure of the triple slice co-cultures to METH gradually
augmented dopamine release evoked by METH challenge. The
augmentation of dopamine release required repeated exposure for
several days. Furthermore, the repeated METH-induced augmen-
tation maintained even after the withdrawal of METH for 4 and 7
days, suggesting this phenomenon is based on long-lasting
neuroadaptive changes in the dopaminergic neurons. However,
the augmented effect of repeated METH exposure was bell-
Figure 3. Effect of repeated exposure to METH on dopamine
release in the VTA/NAc/mPFC triple slice co-cultures. (A) The
triple slice co-cultures were repeatedly exposed to PBS (open column)
or METH (10 mM; closed column) in KRH buffer for 30 min every day for
6 days, and the extracellular dopamine level in KRH buffer was
determined after each 30 min time point. Values represent the mean of
the dopamine concentration 6 S.E.M. **p,0.01, ***p,0.001 versus
PBS-exposed slice co-cultures.
###p,0.001 versus METH-exposed slice
co-cultures on the 1st day. n=6. (B) On the day 7, both repeated METH-
and PBS-exposed co-cultures were challenged by METH at a
concentration of 10 mM in KRH buffer for 30 min, and then the
extracellular dopamine level was determined. **p,0.01 versus repeated
PBS-exposed slice co-cultures. n=6. (C) The triple slice co-cultures were
repeatedly exposed to METH (10 mM) for 6 days, and the extracellular
dopamine level was determined at first (Day 1; open column) and 6
days (Day 6; black column). Following the repeated exposure, the slice
co-cultures were cultured in normal medium for 4 and 7 days. After the
withdrawal periods, the slice co-cultures were challenged with METH
(10 mM), and then the extracellular dopamine level was determined
(gray column). **p,0.01, ***p,0.001 versus Day 1 (single METH
treatment). n=8–17. Values represent means of the dopamine
concentration 6 S.E.M.
doi:10.1371/journal.pone.0024865.g003
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of 10 mM. It is well known that METH at higher doses induces
neurotoxicity, including damage to dopaminergic terminals and
neuronal apoptosis [32,33]. In the triple slice co-cultures, we
observed that sustained exposure to higher concentrations of
METH (100 and 1000 mM) for 2 days produced marked
cytotoxicity, while lower concentrations of METH (1 and
10 mM) exhibited little cytotoxicity in all regions by propidium
iodide uptake assay (Figure S1). It has been shown that higher
doses of METH to a neurotoxic regimen reduced the dopamine
release evoked by potassium or METH in the striatum [34].
Therefore, it is possible that the bell-shaped effect observed in this
study may be due to the neurotoxic effect of the higher
concentrations of METH. If the depletion of dopamine contents
was recovered by the withdrawal of METH for several days, it is
possible that the augmentation of dopamine release could be
observed or more enhanced.
Similar to METH, the present results show that repeated
exposure to cocaine and morphine augmented the dopamine
release induced by their challenges. These effects were concen-
tration-dependent. In contrast to METH-induced neurotoxicity,
repeated administration of cocaine induced no neurotoxicity for
dopaminergic neurons in vivo and in vitro [35–37], and there is no
evidence for morphine. Taken together, to our knowledge, this is
the first demonstration showing that repeated exposure to
psychostimulants and morphine induces augmentation of dopa-
mine release, i.e. dopaminergic sensitization in vitro.
In addition to the mesocorticolimbic dopaminergic neurons, the
glutamatergic neurons have been demonstrated to play a critical
role in the induction of behavioral sensitization to psychostimu-
lants and morphine [11,19,38]. The present study shows that co-
treatment with an NMDA receptor antagonist, MK-801, during
repeated METH exposure prevented the repeated METH-
induced dopaminergic sensitization, which corresponds to previ-
ous in vivo findings that the NMDA receptor antagonists prevented
the induction of METH-induced behavioral sensitization [18,39].
The mPFC is a key structure for regulating the firing pattern of
mesocorticolimbic dopaminergic neurons [40]. In the present
study, the repeated METH-induced dopaminergic sensitization
was not observed in the VTA/NAc double slice co-cultures
without the mPFC slice, suggesting an essential role of mPFC in
the triple slice co-culture. Corresponding to these results,
excitotoxic lesion of the mPFC prevented the METH-induced
behavioral sensitization in vivo [41]. Furthermore, several lines of
evidence suggest that the innervations from the mPFC to the NAc
and VTA through glutamatergic pathway play an essential role in
the induction of behavioral sensitization [11,41,42]. Using the
same triple slice co-cultures, Maeda et al. showed that a single
electrical stimulation of the mPFC slice evoked field excitatory
postsynaptic potential (fEPSP) and spontaneous populations spikes
in the NAc area of the triple slice co-cultures, which were
decreased by NMDA and non-NMDA glutamate receptor
antagonists. Furthermore, they found that cocaine attenuated
the amplitude of fEPSP in a concentration-dependent manner
through activation of D1-like, but not D2-like, dopamine receptors
[26]. These findings suggest that the glutamatergic neurons from
the mPFC are linked, at least, to the NAc and are regulated by
Figure 4. Concentration-dependent effects of repeated expo-
sure to METH, cocaine and morphine on dopamine release in
the VTA/NAc/mPFC triple slice co-cultures. The triple slice co-
cultures were repeatedly exposed to METH (1–1000 mM; A), cocaine (1–
300 mM; B) or morphine (10 and 100 mM; C) in culture medium for
30 min every day for 6 days. On day 7, the slice co-cultures were
challenged with METH (10 mM), cocaine (10 mM) or morphine (100 mM),
respectively, in KRH buffer for 30 min, and then the extracellular
dopamine level was determined. Values represent means of the
dopamine concentration 6 S.E.M. METH, n=3–6; cocaine, n=3–6;
morphine, n=3–7. *p,0.05, ***p,0.001 versus repeated PBS-exposed
slice co-cultures.
doi:10.1371/journal.pone.0024865.g004
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cultures. Thus, it is possible that the corticoaccumbens glutama-
tergic pathway from the mPFC to the NAc may play a role in the
mesocorticolimbic dopaminergic sensitization induced by repeated
exposure to METH through activation of NMDA receptors,
although we have not determined whether the innervations from
the mPFC is linked to the VTA. However, it is also possible that
MK-801 blocked the induction of the dopaminergic sensitization
directly affecting NMDA receptors in the VTA. Further
investigations will be needed to elucidate the roles of glutamatergic
pathways from the mPFC to the NAc and VTA.
In summary, we have reconstructed the mesocorticolimbic
system in vitro using the rat VTA/NAc/mPFC triple slice co-
culture and demonstrated repeated dopaminergic sensitization by
psychostimulants and morphine. Moreover, our in vitro system
confirmed that NMDA receptors and the mPFC are essential for
the induction of the dopaminergic sensitization, at least, by
METH. There are few culture systems that reconstruct the
mesocorticolimbic dopaminergic system including the VTA, NAc
and mPFC and are also available for long-term analysis in vitro.
Therefore, this model provides unique opportunities for studying
the neural and molecular mechanisms underlying certain
processes relevant to behavioral sensitization to drugs of abuse.
Materials and Methods
Materials
D,L-METH hydrochloride was purchased from Dainippon
Pharmaceutical Co. (Osaka, Japan). Morphine hydrochloride
and cocaine hydrochloride were purchased from Takeda Chem-
ical Industries (Osaka, Japan). MDMA hydrochloride was a gift
from Dr. Tatsunori Iwamura (Matsuyama University, Mat-
suyama). (+)-MK-801 hydrogen maleate, an NMDA receptor
antagonist, was purchased from Sigma (St Louis, MO, USA).
Drugs were dissolved in PBS, and then diluted in the culture
medium.
Preparation of rat mesocorticolimbic triple slice
co-cultures
All animal care and experimental procedures were approved by the
Kyoto University Animal Research Committee. Organotypic slice co-
cultures were prepared according to the methods described previously
[26,43], with slight modifications. Briefly, both male and female
Sprague-Dawley rat pups at postnatal days 3–4 (Nihon SLC, Shizuoka,
Japan) were anesthetized by hypothermia, and the brains were
removed from the skull and separated into two hemispheres. Coronal
sections (350 mm thickness) were prepared under sterile conditions with
a tissue chopper (Narishige, Tokyo, Japan) at the mesencephalic and
telencephalic levels. Tissue samples were dissected for the mesence-
phalic slice including the VTA, the ventral striatal slice including the
NAc and the mPFC slice including the cingulate gyrus and infralimbic
cortex, which were identified by visual inspection with the aid of the
Atlas of the developing rat brain [44]. Each slice containing the VTA,
NAc or mPFC region was arranged so that they contacted each other.
Three setsof the triple sliceswere placedon 30 mmMillicell-CMinsert
membranes (pre size 0.4 mm; Millipore, Billerica, MA, USA), and the
inserts were transfered to a six-well culture plate. Culture medium,
consisting of 50% minimal essential medium/HEPES, 25% Hank’s
balanced salt solution and 25% heat-inactivated horse serum (Gibco,
Invitrogen Japan, Tokyo, Japan) supplemented with 6.5 mg/ml
glucose and 2 mM L-glutamine, was supplied at a volume of 0.7 ml
per well. The triple slice co-cultures were maintained at the liquid/air
interface for 18 days in an incubator at 37uCi na5 %C O 2 humidified
atmosphere, and subsequently used in experiments. The culture
Figure 5. Involvement of NMDA receptors and mPFC in the
repeated METH exposure-induced augmentation of dopamine
release. (A) The VTA/NAc/mPFC triple slice co-cultures were co-
exposed to PBS or METH (10 mM) with (closed column) or without (open
column) the NMDA receptor antagonist MK-801 (10 mM) in culture
medium for 30 min every day for 6 days. On day 7, the triple slice co-
cultures were challenged with METH (10 mM) in KRH buffer for 30 min
in the absence of MK-801, and then the extracellular dopamine level
was determined. n=3–6. (B) The VTA/NAc/mPFC triple slice co-cultures
(open columns) and the VTA/NAc double slice co-cultures without the
mPFC slices (closed columns) were repeatedly exposed to PBS or METH
(10 mM) in culture medium for 30 min every day for 6 days. On day 7,
the triple and double slice co-cultures were challenged with METH
(10 mM) in KRH buffer for 30 min, and then the extracellular dopamine
level was determined. Values represent means of the dopamine
concentration 6 S.E.M. n=3–7. *p,0.05, *** p,0.001.
doi:10.1371/journal.pone.0024865.g005
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Immunohistochemistry
Slice co-cultures were fixed with 0.1 M phosphate buffer
containing 4% paraformaldehyde and 4% sucrose for 2 hr. After
washing with PBS, fixed cultures were permeabilized and blocked
with PBS containing 0.2% Triton X-100 and 10% fetal calf serum
for 1 hr. The cultures were then incubated overnight at 4uC with
rabbit anti-TH polyclonal antibody (1:200, AB-152, Chemicon
International, Temecula, CA, USA), and washed with PBS three
times. The cultures were incubated for 1 hr in a secondary
antibody solution containing either Alexa Fluor 488 goat anti-
rabbit IgG (1:200, Molecular Probes, Eugene, OR, USA), or
biotinylated anti-rabbit IgG (1:200, Vector Laboratories, Burlin-
game, CA, USA) and washed with PBS three times.
For immunofluorescent staining, the cultures were transferred
to glass slides and cover-slipped using Vectashield hard-set
mounting medium (Vector Lab). Immunofluorescence was
visualized using a Nikon Diaphot 200 microscope equipped with
a laser scanning confocal imaging system (MRC-1024, Bio-Rad
Laboratories, Hercules, CA). For immunostaining using the biotin-
avidin peroxidase method, cultures were treated for 1 hr with
avidin–biotinylated horseradish peroxidase complex (Vectastain
Elite ABC kit, Vector Lab) at room temperature. After a further
wash with 50 mM Tris-buffered saline, peroxidase was visualized
with 0.07% 3,39-diaminobenzidine and 0.018% H2O2. Specimens
were dehydrated through a graded ethanol series and mounted on
glass slides with glycerol for observation with a microscope using
bright-field illumination.
Western blot
After 18 days culture, slice co-cultures were separated into
VTA, NAc and mPFC parts under dissecting microscope, and
these parts from 4 culture inserts were harvested in 100 mL Lysis
buffer (20 mM Tris-HCl, 1% Triton-X (Nacalai tesque, Kyoto,
Japan) and 1% protease inhibitor cocktail (Merck, Darmstadt,
Germany)). After harvest, these parts were homogenized, sonicat-
ed and centrifuged at 600 g for 5 min, and protein concentration
of resulting supernatants were measured by the bicinchoninic acid
protein assay (Thermo Fisher, MA, USA). Equal volume of 26
Laemmli sample buffer were added to supernatants and stored at
220uC until use. Thawed samples were analyzed by SDS-PAGE,
transferred to polyvinylidene difluoride membrane and probed
with anti-dopamine transporter antibody (1:1000; D6944, Sigma-
Aldrich, St Louis, MO, USA) or anti-Na
+/K
+-ATPase (1:10000;
Abcam, Cambridge, UK), followed by probing with horseradish
peroxidase-conjugate secondary antibody. Proteins were visualized
by Immobilon Western HRP substrate (Millipore, Billerica, MA,
USA) and detected by X-ray film.
Measurement of dopamine release
Measurement of extracellular dopamine levels was performed as
previously described [43], with slight modifications. Briefly, for
measurement of extracellular dopamine levels, culture inserts were
transferred and washed in 0.7 mL KRH buffer (146 mM NaCl,
2.7 mM KCl, 1 mM MgCl2, 1.2 mM CaCl2, 10 mM D-glucose,
15 mM HEPES, 5 mM HEPES-Na, 0.2 mM ascorbic acid;
pH 7.4) three times. After the washes, the inserts were preincu-
bated in KRH buffer for 15 min, then transferred to 0.7 mL KRH
buffer containing drugs and incubated for 30 min. After
incubation, KRH buffer was collected into vials, and acid solution
was added that contained 1 M HClO4, 100 mM Na2S2O5 and
10 mM EDTA. To quantify dopamine concentration, the
collected aliquot (20 ml) was automatically injected and analyzed
by high performance liquid chromatography with an electro-
chemical detection system (Eicom, Kyoto, Japan). Dopamine was
quantified by reference to a linear calibration curve ranging from
0.1 to 100 nM. The detection limits for dopamine were estimated
to be approximately 10 pM per 20 ml sample.
Statistical analysis
Data are presented as the mean 6 S.E.M. Differences between
two groups were compared using the Student’s t-test. Data with
more than two groups were compared by one-way analysis of
variance (ANOVA), followed by the Dunnett’s multiple compar-
ison test. The time-course data was analyzed by two-way ANOVA
for repeated measures, followed by the Bonferroni post-hoc test.
Differences of p,0.05 were considered statistically significant.
Supporting Information
Figure S1 Effect of sustained exposure to METH on the
propidium iodide (PI) uptake in the VTA/NAc/mPFC
triple slice co-cultures. The triple slice co-cultures were
exposed to PBS, METH (1–1000 mM) or NMDA (300 mM) in the
presence of PI (5 mg/ml). After 2 days incubation, the PI
fluorescence of each slice was observed with an inverted
fluorescence microscope with a rhodamine filter set. The triple
slice co-cultures exposed to N-methyl-D-aspartate (NMDA;
300 mM) for 2 days were used to determine the degree of the
standard injury. Representative photomicrographs of PI fluores-
cence in the NAc (upper), mPFC (middle) and VTA (bottom)
regions, respectively, are shown. Sustained exposure of the slice
co-cultures to METH for 2 days exhibited concentration-
dependent increases in PI fluorescence in each of the NAc,
mPFC, and VTA regions. In all regions, a small number of PI
positive cells was observed with 10 mM METH, and marked
increases of PI positive cells were observed with 100 and 1000 mM
METH. The total number of PI positive cells in the mPFC region
was greater than in the other two regions. This is likely due to the
fact that in the mPFC region, there were a greater total number of
cells in the original triple slice co-cultures.
(TIF)
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